Author/Authors :
Tekin، نويسنده , , Abdullah and Tekin، نويسنده , , G?knur and Güzelsoy، نويسنده , , Deniz and Kaya، نويسنده , , Ay?em and Gürel، نويسنده , , Ci?dem Vural and Yi?it، نويسنده , , Zerrin and Ulutin، نويسنده , , Turgut، نويسنده ,
Abstract :
Hyperlipidemic patients with coronary heart disease were treated with atorvastatin, and its effects on hemostatic and inflammatory parameters were assessed. After 3 months of therapy, the plasma levels of plasminogen activator inhibitor, prothrombin fragment 1+2, highly sensitive C-reactive protein, von Willebrand factor, and fibrinogen were significantly reduced; no significant reductions were observed in lipoprotein(a) and tissue plasminogen activator antigen levels.
